Published in J Acquir Immune Defic Syndr on December 01, 2001
CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med (2006) 22.76
Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell (1997) 11.35
Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science (1995) 9.09
Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial. Lancet (2009) 7.96
Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy. Nat Med (2000) 4.12
Comparison of attendance and emergency admission patterns at accident and emergency departments in and out of London. BMJ (1993) 4.08
Stability of intelligence from preschool to adolescence: the influence of social and family risk factors. Child Dev (1993) 3.64
Identification of targets of leptin action in rat hypothalamus. J Clin Invest (1996) 3.49
Response of melanocortin-4 receptor-deficient mice to anorectic and orexigenic peptides. Nat Genet (1999) 3.37
T-cell receptor variable gene products and early HIV-1 infection. Lancet (1992) 3.20
Sputum induction for diagnosis of Pneumocystis carinii pneumonia. Lancet (1989) 3.15
Patients with fatigue in general practice: a prospective study. BMJ (1993) 3.14
Effect of computer-assisted self-interviews on reporting of sexual HIV risk behaviours in a general population sample: a methodological experiment. AIDS (2001) 3.03
1998 revision to the British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals. BHIVA Guidelines Writing Committee. Lancet (1998) 2.82
Loss of blood CD11c(+) myeloid and CD11c(-) plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load. Blood (2001) 2.57
Energy expenditure and wasting in human immunodeficiency virus infection. N Engl J Med (1995) 2.50
Fatal septicaemia after fibroid embolisation. Lancet (1999) 2.48
Gastrointestinal manifestations of HIV infection. Lancet (1996) 2.38
Leptin increases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus. Diabetes (1997) 2.32
Interaction of Shc with the zeta chain of the T cell receptor upon T cell activation. Science (1993) 2.25
Successful use of genotypic resistance testing in HIV-1-infected individuals with detectable viraemia between 50 and 1000 copies/ml. AIDS (2006) 2.21
Relative antiviral efficacy of ritonavir-boosted darunavir and ritonavir-boosted tipranavir vs. control protease inhibitor in the POWER and RESIST trials. HIV Med (2007) 2.19
The human p50csk tyrosine kinase phosphorylates p56lck at Tyr-505 and down regulates its catalytic activity. EMBO J (1992) 2.16
Tyrosine kinase-stimulated guanine nucleotide exchange activity of Vav in T cell activation. Science (1993) 2.10
Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma. J Clin Oncol (2005) 2.07
Melanocortin receptors in leptin effects. Nature (1997) 2.01
British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy. HIV Med (2003) 1.94
Polymorphisms in FKBP5 are associated with peritraumatic dissociation in medically injured children. Mol Psychiatry (2005) 1.91
The incidence of AIDS-defining illnesses at a current CD4 count ≥ 200 cells/μL in the post-combination antiretroviral therapy era. Clin Infect Dis (2013) 1.91
Patient-delivered partner medication in the UK: an unlawful but popular choice. Int J STD AIDS (2007) 1.91
Genome-wide association study of Alzheimer's disease. Transl Psychiatry (2012) 1.88
Increased numbers of acute hepatitis C infections in HIV positive homosexual men; is sexual transmission feeding the increase? Sex Transm Infect (2004) 1.79
Purification and characterization of recombinant human p50csk protein-tyrosine kinase from an Escherichia coli expression system overproducing the bacterial chaperones GroES and GroEL. Proc Natl Acad Sci U S A (1995) 1.78
Impact of HIV infection on mortality in young men in a London health authority. BMJ (1992) 1.78
Prospective analysis of patterns of weight change in stage IV human immunodeficiency virus infection. Am J Clin Nutr (1993) 1.71
Endoscopic balloon dilatation versus endoscopic sphincterotomy for the removal of bile duct stones: a prospective randomised trial. Gut (2003) 1.70
Universal HIV screening of pregnant women in England: cost effectiveness analysis. BMJ (1999) 1.68
Loss of CD4+ T cell proliferative ability but not loss of human immunodeficiency virus type 1 specificity equates with progression to disease. J Infect Dis (2000) 1.66
Fluconazole resistant candida in AIDS. J Infect (1991) 1.64
Incomplete sulphomucin-secreting intestinal metaplasia for gastric cancer. Preliminary data from a prospective study from three centres. Gut (1985) 1.64
The steady-state pharmacokinetics of efavirenz and nevirapine when used in combination in human immunodeficiency virus type 1-infected persons. J Infect Dis (2001) 1.62
Transport function and regulation of mitochondrial uncoupling proteins 2 and 3. J Biol Chem (1999) 1.61
Rectal chlamydia--a reservoir of undiagnosed infection in men who have sex with men. Sex Transm Infect (2009) 1.59
Time to use text reminders in genitourinary medicine clinics. Int J STD AIDS (2008) 1.59
Texting decreases the time to treatment for genital Chlamydia trachomatis infection. Sex Transm Infect (2006) 1.57
The OB protein (leptin) pathway--a link between adipose tissue mass and central neural networks. Horm Metab Res (1996) 1.57
Managing tuberculosis and HIV infection. BMJ (1992) 1.56
A genome-wide association study of post-traumatic stress disorder identifies the retinoid-related orphan receptor alpha (RORA) gene as a significant risk locus. Mol Psychiatry (2012) 1.55
Patients who consult with tiredness: frequency of consultation, perceived causes of tiredness and its association with psychological distress. Br J Gen Pract (1994) 1.53
Emergency laparotomy in patients with AIDS. Br J Surg (1991) 1.53
Changes in acquired immunodeficiency syndrome-related lymphoma since the introduction of highly active antiretroviral therapy. Blood (2000) 1.52
Amino acid sequence of the triple-helical domain of human collagen type VI. J Biol Chem (1988) 1.52
Regulation of src family tyrosine kinases in lymphocytes. Trends Biochem Sci (1993) 1.49
The role of immune suppression and HHV-8 in the increasing incidence of HIV-associated multicentric Castleman's disease. Ann Oncol (2009) 1.46
Responses to highly active antiretroviral therapy and clinical events in patients with a low CD4 cell count: late presenters vs. late starters. HIV Med (2010) 1.45
Mucin secretion in inflammatory bowel disease: correlation with disease activity and dysplasia. Gut (1982) 1.43
Small intestinal transit, absorption, and permeability in patients with AIDS with and without diarrhoea. Gut (1999) 1.42
Failure to maintain patient access to GUM clinics. Sex Transm Infect (2004) 1.41
Preliminary report: genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis. Br Heart J (1995) 1.41
Amphitropic proteins: a new class of membrane proteins. Trends Biochem Sci (1988) 1.40
Sexual health of adults working in pornographic films. Int J STD AIDS (2009) 1.40
Switching from a PI-based to a PI-sparing regimen for management of metabolic or clinical fat redistribution. AIDS Read (2000) 1.40
"I plan to have the HIV test"--predictors of testing intention in women attending a London antenatal clinic. AIDS Care (1993) 1.40
Is supplementation with elemental diet feasible in patients undergoing pelvic radiotherapy? Clin Nutr (2005) 1.39
Microscopy and culture for Trichomonas vaginalis: are both required? Int J STD AIDS (2006) 1.39
Eating disorders in men with HIV infection. Br J Psychiatry (1992) 1.39
Gender dominance in the work setting: implications for dietitians. J Am Diet Assoc (1993) 1.39
Tuberculosis antigen-specific immune responses can be detected using enzyme-linked immunospot technology in human immunodeficiency virus (HIV)-1 patients with advanced disease. Clin Exp Immunol (2007) 1.39
Regulation of the p59fyn protein tyrosine kinase by the CD45 phosphotyrosine phosphatase. Eur J Immunol (1992) 1.32
Morphological and mucus secretion criteria for differential diagnosis of solitary ulcer syndrome and non-specific proctitis. J Clin Pathol (1982) 1.31
Identification and functional analysis of novel human melanocortin-4 receptor variants. Diabetes (1999) 1.30
Central infusion of GLP-1, but not leptin, produces conditioned taste aversions in rats. Am J Physiol (1997) 1.30
Whose health is it? Views about decision-making and information-seeking from people with HIV infection and their professional carers. AIDS Care (1994) 1.30
CD4 cell count and initiation of antiretroviral therapy: trends in seven UK centres, 1997-2003. HIV Med (2007) 1.30
Intestinal inflammation, ileal structure and function in HIV. AIDS (1996) 1.29
Diacylglycerol in large alpha-actinin/actin complexes and in the cytoskeleton of activated platelets. Nature (1985) 1.29
The inositol 5'-phosphatase SHIP binds to immunoreceptor signaling motifs and responds to high affinity IgE receptor aggregation. J Biol Chem (1996) 1.28
Direct stimulation of Vav guanine nucleotide exchange activity for Ras by phorbol esters and diglycerides. Mol Cell Biol (1994) 1.27
Tyrosine phosphorylation of CD45 phosphotyrosine phosphatase by p50csk kinase creates a binding site for p56lck tyrosine kinase and activates the phosphatase. Mol Cell Biol (1994) 1.26
Leptin receptor long-form splice-variant protein expression in neuron cell bodies of the brain and co-localization with neuropeptide Y mRNA in the arcuate nucleus. J Histochem Cytochem (1999) 1.26
Sexual dysfunction in HIV-positive men is multi-factorial: a study of prevalence and associated factors. AIDS Care (2007) 1.25
Severe exercise hypoxaemia with normal or near normal X-rays: a feature of Pneumocystis carinii infection. Lancet (1988) 1.24
Catalytic domains of the LAR and CD45 protein tyrosine phosphatases from Escherichia coli expression systems: purification and characterization for specificity and mechanism. Biochemistry (1992) 1.23
Intraventricular leptin reduces food intake and body weight of lean rats but not obese Zucker rats. Horm Metab Res (1996) 1.23
Impact of antiretroviral choice on hypercholesterolaemia events: the role of the nucleoside reverse transcriptase inhibitor backbone. HIV Med (2005) 1.22
Summary of the II International Symposium on Cytomegalovirus. Antiviral Res (1998) 1.21
Contamination of endoscopes used in AIDS patients. Lancet (1989) 1.21
Candida and AIDS: evidence for protective antibody. Lancet (1988) 1.20
Central infusion of melanocortin agonist MTII in rats: assessment of c-Fos expression and taste aversion. Am J Physiol (1998) 1.20
TRIZAL study: switching from successful HAART to Trizivir (abacavir-lamivudine-zidovudine combination tablet): 48 weeks efficacy, safety and adherence results. HIV Med (2003) 1.20
Polymerase chain reaction evidence for human immunodeficiency virus 1 neutralization by passive immunization in patients with AIDS and AIDS-related complex. Proc Natl Acad Sci U S A (1990) 1.19
A prospective single centre study comparing computed tomography pneumocolon against colonoscopy in the detection of colorectal neoplasms. Gut (2000) 1.18